 long-term benzodiazepin user year particip discontinu program object clinic statu use benzodiazepin psychotrop drug follow-up patient depend benzodiazepin particip discontinu studi method benzodiazepine-depend patient entri taper discontinu program program undergon drug follow-up inform structur telephon interview mail questionnair global sever scale anxieti depress hopkin symptom checklist time follow-up year mean SD interv follow-up year result outcom follow-up patient discontinu program benzodiazepin unsuccess taper group no-tap group moder anxieti patient benzodiazepin follow-up patient nonbenzodiazepin psychotrop agent antidepress conclus high percentag patient benzodiazepine-fre follow-up anxieti depress present mani patient patient benzodiazepin chronic recurr anxieti depress physic depend